ABBV - AbbVie Inc
Earnings Results

AbbVie Inc ( $ABBV )

Recent earnings result

  1. AbbVie EPS beats by $0.11, beats on revenue, raises guidance

Events & Presentations

AbbVie Inc ABBV CEO Rick Gonzalez on Q2 2020 Results

Supporting docs

  1. Listen to webcast

Top Stories (ABBV)

Events & Annual meetings

Title Date Webcast
AbbVie Inc ABBV CEO Rick Gonzalez on Q2 2020 Results 8/2/2020 webcast
AbbVie to Present at the Wolfe Research Inaugural Healthcare Conference 11/06/19 8:30 am CST webcast
AbbVie to Host Third-Quarter 2019 Earnings Conference Call 11/01/19 8:00 am CDT webcast
AbbVie to Present at the Morgan Stanley Healthcare Conference 09/10/19 10:10 am CDT webcast
AbbVie to Host Second-Quarter 2019 Earnings Conference Call 07/26/19 8:00 am CDT webcast PDF

AbbVie Inc. discovers, develops, manufactures, and sells pharmaceutical products in the United States, Japan, Germany, Canada, Italy, Spain, the Netherlands, the United Kingdom, Brazil, and internationally. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Beh├žet's diseases

Videos about AbbVie Inc


The Content is made available for informational purposes only. The Content may not be complete and may be subject to change.
The Content is provided without any warranty of any kind, either express or implied.
We have collected the events here to help investors easily find the informations they need.
These are manually collected by our researchers directly from Official IR pages and not third party sources.

Recent results

Books we are reading